Updated:
LifeOmic Health
LifeOmic Health is a US-based family office investing in digital health, AI, and precision medicine across Boston, San Francisco, Indianapolis, and Palo...
LifeOmic Health
LifeOmic Health operates as a single-family office with a focus on digital health and healthcare technology, though the founding family and exact year of establishment are not public. The firm's multi-city presence in Boston, San Francisco, Indianapolis, and Palo Alto suggests a distributed investment team that sources deals across biotech, health data analytics, and AI/ML-enabled clinical tools. The strategy targets companies at the intersection of life sciences and software. LifeOmic Health is known for direct investments in precision medicine platforms, real-world evidence analytics, and digital therapeutics — asset classes that span venture-stage equity and growth capital. The portfolio is understood to include firms developing AI-driven diagnostic tools and health data infrastructure. Geographic focus is primarily North America, with some exposure to European health-tech opportunities. The team size and deployment volume are not disclosed publicly. No philanthropic or adjacent vehicles have been named. Recent operational posture is unclear due to limited public filings or press coverage. LifeOmic Health's structural differentiator is its explicit focus on the convergence of AI and healthcare — a narrow mandate uncommon among family offices. This specialization allows it to act as a strategic partner for early-stage health-tech companies, but the lack of disclosed principals or track record limits external due diligence.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Additional offices
San Francisco, CA, United States · Indianapolis, IN, United States · Palo Alto, CA, United States
Sector focus
Frequently asked questions
What investment stages does LifeOmic Health typically target?
LifeOmic Health appears to focus on venture-stage and growth equity in digital health and AI-driven healthcare. Its portfolio likely includes seed to Series C companies developing clinical software, diagnostics, and data platforms.
Does LifeOmic Health participate in direct deals or fund commitments?
Based on the firm's profile as a family office with multiple offices, LifeOmic Health likely pursues direct co-investments and may also commit to healthcare-focused venture funds. The exact structure is not disclosed.
Which sectors does LifeOmic Health explicitly avoid?
The firm's public focus is on digital health and healthcare technology. It likely does not invest in non-healthcare sectors such as real estate, energy, or consumer goods. Specific exclusions are not documented.
Where does the underlying wealth come from?
The wealth origin is not publicly disclosed. The firm's name suggests a connection to the broader LifeOmic ecosystem, which includes a health data company, but no family or principal is named.
How does LifeOmic Health source proprietary deal flow?
With offices in four US innovation hubs, LifeOmic Health likely leverages relationships with academic medical centers, venture firms, and health-tech accelerators. Its narrow sector focus may also attract inbound referrals from portfolio companies.
Is LifeOmic Health structured as a pure family office or does it operate like a venture firm?
LifeOmic Health is structured as a family office, but its multi-city presence and sector specialization mean it functions similarly to a dedicated health-tech venture investor. It likely makes direct investments without a commingled fund structure.
What is LifeOmic Health's known posture on co-investments alongside external GPs?
Co-investments are a common family office strategy, and LifeOmic Health's dispersed team and sector focus suggest it may co-invest with specialist healthcare venture capital firms. No specific deals have been confirmed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: